During the past decade, IRCCS Centro San Giovanni di Dio Fatebenefratelli conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IRCCS Centro San Giovanni di Dio Fatebenefratelli" #1 sponsor was "IRCCS Centro San Giovanni di Dio Fatebenefratelli" with 8 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Washington University School of Medicine" with 3 trials sponsored, "TauRx Therapeutics Ltd" with 2 trials sponsored and "Alector Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Centro San Giovanni di Dio Fatebenefratelli" #1 collaborator was "Alzheimer's Association" with 3 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "Accelerating Medicines Partnership (AMP)" with 2 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Centro San Giovanni di Dio Fatebenefratelli" are "Alzheimer's Disease" (7 trials), "Alzheimer Disease" (5 trials), "Dementia" (4 trials), "Alzheimers Disease" (3 trials) and "Alzheimers Disease, Familial" (3 trials). Many other conditions were trialed in "IRCCS Centro San Giovanni di Dio Fatebenefratelli" in a lesser frequency.

Most popular intervention types in "IRCCS Centro San Giovanni di Dio Fatebenefratelli" are "Drug" (18 trials), "Behavioral" (3 trials), "Device" (3 trials), "Dietary Supplement" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Gantenerumab" (7 trials), "E2814" (2 trials), "Lecanemab" (2 trials) and "Matching Placebo (E2814)" (2 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Centro San Giovanni di Dio Fatebenefratelli" are 27 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Centro San Giovanni di Dio Fatebenefratelli". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in IRCCS Centro San Giovanni di Dio Fatebenefratelli, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Centro San Giovanni di Dio Fatebenefratelli, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".